331 related articles for article (PubMed ID: 18468387)
1. Solid-state characterization and dissolution properties of bicalutamide-beta-cyclodextrin inclusion complex.
Patil AL; Pore YV; Kuchekar BS; Late SG
Pharmazie; 2008 Apr; 63(4):282-5. PubMed ID: 18468387
[TBL] [Abstract][Full Text] [Related]
2. Effect of beta-cyclodextrin and hydroxypropyl beta-cyclodextrin complexation on physicochemical properties and antimicrobial activity of cefdinir.
Aleem O; Kuchekar B; Pore Y; Late S
J Pharm Biomed Anal; 2008 Jul; 47(3):535-40. PubMed ID: 18367363
[TBL] [Abstract][Full Text] [Related]
3. Preparation and characterization of simvastatin/hydroxypropyl-beta-cyclodextrin inclusion complex using supercritical antisolvent (SAS) process.
Jun SW; Kim MS; Kim JS; Park HJ; Lee S; Woo JS; Hwang SJ
Eur J Pharm Biopharm; 2007 Jun; 66(3):413-21. PubMed ID: 17240129
[TBL] [Abstract][Full Text] [Related]
4. Preparation and characterization of inclusion complexes of prazosin hydrochloride with beta-cyclodextrin and hydroxypropyl-beta-cyclodextrin.
Liu L; Zhu S
J Pharm Biomed Anal; 2006 Jan; 40(1):122-7. PubMed ID: 16095859
[TBL] [Abstract][Full Text] [Related]
5. Inclusion complexes of tadalafil with natural and chemically modified beta-cyclodextrins. I: preparation and in-vitro evaluation.
Badr-Eldin SM; Elkheshen SA; Ghorab MM
Eur J Pharm Biopharm; 2008 Nov; 70(3):819-27. PubMed ID: 18655829
[TBL] [Abstract][Full Text] [Related]
6. Development and characterization of bicalutamide-poloxamer F68 solid dispersion systems.
Sancheti PP; Vyas VM; Shah M; Karekar P; Pore YV
Pharmazie; 2008 Aug; 63(8):571-5. PubMed ID: 18771004
[TBL] [Abstract][Full Text] [Related]
7. Dissolution properties and characterization of halofantrine-2-hydroxypropyl-beta-cyclodextrin binary systems.
Onyeji CO; Omoruyi SI; Oladimeji FA
Pharmazie; 2007 Nov; 62(11):858-63. PubMed ID: 18065103
[TBL] [Abstract][Full Text] [Related]
8. Improvement of dissolution properties of furosemide by complexation with beta-cyclodextrin.
Ozdemir N; Ordu S
Drug Dev Ind Pharm; 1998 Jan; 24(1):19-25. PubMed ID: 15605593
[TBL] [Abstract][Full Text] [Related]
9. Solid-state characterization and dissolution profiles of the inclusion complexes of omeprazole with native and chemically modified beta-cyclodextrin.
Figueiras A; Carvalho RA; Ribeiro L; Torres-Labandeira JJ; Veiga FJ
Eur J Pharm Biopharm; 2007 Sep; 67(2):531-9. PubMed ID: 17451924
[TBL] [Abstract][Full Text] [Related]
10. Solubility enhancement of celecoxib using beta-cyclodextrin inclusion complexes.
Rawat S; Jain SK
Eur J Pharm Biopharm; 2004 Mar; 57(2):263-7. PubMed ID: 15018983
[TBL] [Abstract][Full Text] [Related]
11. Nanosized bicalutamide and its molecular structure in solvents.
Le Y; Ji H; Chen JF; Shen Z; Yun J; Pu M
Int J Pharm; 2009 Mar; 370(1-2):175-80. PubMed ID: 19101616
[TBL] [Abstract][Full Text] [Related]
12. Physicochemical characteristics and bioavailability of a novel intestinal metabolite of ginseng saponin (IH901) complexed with beta-cyclodextrin.
Lee PS; Han JY; Song TW; Sung JH; Kwon OS; Song S; Chung YB
Int J Pharm; 2006 Jun; 316(1-2):29-36. PubMed ID: 16574357
[TBL] [Abstract][Full Text] [Related]
13. In vitro and in vivo evaluation of an amylobarbitone/hydroxypropyl-beta-cyclodextrin complex prepared by a freeze-drying method.
Fathy M; Sheha M
Pharmazie; 2000 Jul; 55(7):513-7. PubMed ID: 10944779
[TBL] [Abstract][Full Text] [Related]
14. Enhanced solubility and dissolution rate of lamotrigine by inclusion complexation and solid dispersion technique.
Shinde VR; Shelake MR; Shetty SS; Chavan-Patil AB; Pore YV; Late SG
J Pharm Pharmacol; 2008 Sep; 60(9):1121-9. PubMed ID: 18718114
[TBL] [Abstract][Full Text] [Related]
15. Preparation and solid-state characterization of bupivacaine hydrochloride cyclodextrin complexes aimed for buccal delivery.
Jug M; Maestrelli F; Bragagni M; Mura P
J Pharm Biomed Anal; 2010 May; 52(1):9-18. PubMed ID: 20004541
[TBL] [Abstract][Full Text] [Related]
16. Inclusion complexes of noscapine in beta-cyclodextrin offer better solubility and improved pharmacokinetics.
Madan J; Dhiman N; Parmar VK; Sardana S; Bharatam PV; Aneja R; Chandra R; Katyal A
Cancer Chemother Pharmacol; 2010 Feb; 65(3):537-48. PubMed ID: 19597818
[TBL] [Abstract][Full Text] [Related]
17. Physicochemical, in silico and in vivo evaluation of a danazol-beta-cyclodextrin complex.
Jadhav GS; Vavia PR
Int J Pharm; 2008 Mar; 352(1-2):5-16. PubMed ID: 18023545
[TBL] [Abstract][Full Text] [Related]
18. Enhancement of dissolution and oral bioavailability of gliquidone with hydroxy propyl-beta-cyclodextrin.
Sridevi S; Chauhan AS; Chalasani KB; Jain AK; Diwan PV
Pharmazie; 2003 Nov; 58(11):807-10. PubMed ID: 14664337
[TBL] [Abstract][Full Text] [Related]
19. Preformulation study of the inclusion complex warfarin-beta-cyclodextrin.
Zingone G; Rubessa F
Int J Pharm; 2005 Mar; 291(1-2):3-10. PubMed ID: 15707726
[TBL] [Abstract][Full Text] [Related]
20. Preparation and characterization of inclusion complex of norflurazon and beta-cyclodextrin to improve herbicide formulations.
Villaverde J; Morillo E; Pérez-Martínez JI; Ginés JM; Maqueda C
J Agric Food Chem; 2004 Feb; 52(4):864-9. PubMed ID: 14969543
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]